Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study. - Leo F; Ortoncelli M; Cascio Ingurgio R; Galli B; Grigolato L; Paganini C; Maurelli M; Di Brizzi EV; Lauletta G; Barei F; Fiasconaro CA; Casale Alloa M; et al. (American journal of clinical dermatology, 2025)